By Katherine Hamilton
Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday.
Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed.
Five Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
June 04, 2025 19:32 ET (23:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。